Animal nutrition

Balchem Corporation Reports Fourth Quarter and Full Year 2023 Financial Results

Retrieved on: 
Friday, February 16, 2024
CFO, Human nutrition, Animal nutrition, Mineral, ID, Food, GAAP, Nutrient, Public expenditure

Financial Results for the Fourth Quarter of 2023:

Key Points: 
  • Financial Results for the Fourth Quarter of 2023:
    The Human Nutrition & Health segment generated fourth quarter sales of $138.0 million, an increase of $7.6 million or 5.8% compared to the prior year quarter.
  • The Animal Nutrition & Health segment generated quarterly sales of $58.2 million, a decrease of $6.6 million or 10.2% compared to the prior year quarter.
  • I am excited about our future.”
    A quarterly conference call will be held on Friday, February 16, 2024, at 11:00 AM Eastern Time (ET) to review fourth quarter 2023 results.
  • Balchem Corporation reports three business segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products.

dsm-firmenich reports full year 2023 results

Retrieved on: 
Thursday, February 15, 2024
DSM, ANH, Nutrition, Firmenich, Animal nutrition, Vitamin, Culture, Beauty, TTH, Life, Climate change, Element, Acceleration, Science, Annual, HNC, Fine chemical

2 Represents the figures on an IFRS basis, including the Firmenich results as of the merger date May 8, 2023.

Key Points: 
  • 2 Represents the figures on an IFRS basis, including the Firmenich results as of the merger date May 8, 2023.
  • We accelerated our plans for driving through additional self-help measures and advanced the review of all our business segments.
  • In Q4 2023, the program generated an about €10 million savings contribution to Adjusted EBITDA.
  • At the Annual General Meeting on May 7, 2024, dsm-firmenich's Board of Directors will propose a cash dividend of €2.50 per share for the financial year 2023.

Balchem Corporation Reports Third Quarter Sales of $229.9 Million, with Net Earnings of $29.1 Million, GAAP EPS of $0.90, and Adjusted EPS of $1.04

Retrieved on: 
Friday, October 27, 2023
Human nutrition, Food, Public expenditure, GAAP, Acquisition, Animal nutrition, Calumet Specialty Products Partners, ID, Bergstrom, Mineral, CFO, Nutrient, Bank, Pharmaceutical industry, Music

Financial Results for the Third Quarter of 2023:

Key Points: 
  • Financial Results for the Third Quarter of 2023:
    The Human Nutrition & Health segment generated record quarterly sales of $144.5 million, an increase of $1.8 million, or 1.3%, compared to the prior year quarter.
  • The Animal Nutrition & Health segment generated quarterly sales of $53.9 million, a decrease of $11.7 million, or 17.8%, compared to the prior year quarter.
  • Ted Harris said, “The Balchem team delivered another solid quarter, once again, highlighting the strength and resilience of our business model.
  • Sales and production of products outside of our reportable segments and other minor business activities are included in "Other and Unallocated".

ADM Reports Third Quarter Earnings per Share of $1.52, $1.63 on an Adjusted Basis

Retrieved on: 
Tuesday, October 24, 2023
Food, Beverage, Manufacturing, Environment, Retail, Food Tech, Other Science, Sustainability, Supply Chain Management, Fitness & Nutrition, Science, Technology, Other Natural Resources, Biotechnology, Agriculture, Natural Resources, Health, Chemicals, Plastics, Agritech, Human nutrition, Insurance, Sale, ADM, Ethanol, Meat, Dicarboxylic acid, Vegetable oil, Starch, Acquisition, Animal nutrition, Segment, International, Hurricane Ida, EPS, Risk management, Sugar substitute, Webcast, Association of Jewish Aging Services, Business, Central Time, Wellness, Video game, Pharmaceutical industry, Financial services, Corporation

South American origination results were higher year-over-year, as the team delivered significantly higher volumes and margins on strong export demand.

Key Points: 
  • South American origination results were higher year-over-year, as the team delivered significantly higher volumes and margins on strong export demand.
  • Effective risk management and higher volumes and margins in Global Trade led to strong results, however, lower year-over-year.
  • In the quarter, there were large net positive mark-to-market timing effects, which were lower than the net positive impacts in the prior year quarter.
  • Other Business results were significantly higher than the prior-year quarter due to improved ADM Investor Services earnings on higher net interest income.

Balchem Corporation Reports Second Quarter Sales of $231.3 Million, with Net Earnings of $30.1 Million, GAAP EPS of $0.93, and Adjusted EPS of $1.06

Retrieved on: 
Friday, July 28, 2023
Mineral, Food, Animal nutrition, Nutrient, GAAP, ID, Public expenditure, Calumet Specialty Products Partners, Human nutrition, Kappa, Bergstrom, CFO, Bank, Real estate, Pharmaceutical industry

Financial Results for the Second Quarter of 2023:

Key Points: 
  • Financial Results for the Second Quarter of 2023:
    The Human Nutrition & Health segment generated quarterly sales of $135.7 million, an increase of $4.0 million, or 3.1%, compared to the prior year quarter.
  • The Animal Nutrition & Health segment generated quarterly sales of $61.3 million, a decrease of $1.3 million, or 2.0%, compared to the prior year quarter.
  • The decrease was driven by lower sales in monogastric markets, partially offset by higher sales in the ruminant species markets.
  • Sales and production of products outside of our reportable segments and other minor business activities are included in "Other and Unallocated."

ADM Reports Second Quarter Earnings per Share of $1.70, $1.89 on an Adjusted Basis

Retrieved on: 
Tuesday, July 25, 2023
Food, Beverage, Manufacturing, Environment, Retail, Food Tech, Other Science, Sustainability, Supply Chain Management, Fitness & Nutrition, Science, Technology, Other Natural Resources, Biotechnology, Agriculture, Natural Resources, Health, Chemicals, Plastics, Agritech, Sugar substitute, ADM, Nutrition, Wellness, Ethanol, Segment, Association of Jewish Aging Services, Wilmar, Business, Risk management, Animal nutrition, Central Time, Dicarboxylic acid, Sale, Human nutrition, Destination marketing organization, Webcast, EPS, Vegetable oil, Meat, International, Starch, Insurance, Financial services, Flour, Fertilizer, Fine chemical, Q2, Corporation

Crushing results were much lower than the record result from the second quarter last year.

Key Points: 
  • Crushing results were much lower than the record result from the second quarter last year.
  • Refined Products and Other results were significantly higher than the prior-year period, achieving a record second quarter.
  • Human Nutrition results were in-line with the second quarter of 2022, as the team effectively managed a challenging demand environment.
  • Other Business results were significantly higher than the prior-year quarter due to improved ADM Investor Services earnings on higher net interest income.

Balchem Corporation Reports Record First Quarter Sales of $232.5 Million, with Net Earnings of $22.7 Million, GAAP EPS of $0.70, and Adjusted EPS of $0.94

Retrieved on: 
Friday, April 28, 2023
Mineral, Food, Animal nutrition, Nutrient, GAAP, ID, Public expenditure, Calumet Specialty Products Partners, Human nutrition, Kappa, EBITDA, Bergstrom, CFO, Growth, Bank, Video game

Sequentially, compared with the fourth quarter of 2022, sales increased 1.7% in the first quarter of 2023 and adjusted earnings from operations increased 14.1%.

Key Points: 
  • Sequentially, compared with the fourth quarter of 2022, sales increased 1.7% in the first quarter of 2023 and adjusted earnings from operations increased 14.1%.
  • The Animal Nutrition & Health segment generated quarterly sales of $64.9 million, a decrease of $4.5 million, or 6.4%, compared to the prior year quarter.
  • Sequentially, compared with the fourth quarter of 2022, sales and adjusted earnings were essentially flat in the first quarter of 2023.
  • Sequentially, compared with the fourth quarter of 2022, sales increased 1.3% in the first quarter of 2023 and adjusted earnings from operations were essentially flat.

ADM Reports First Quarter Earnings per Share of $2.12, $2.09 on an Adjusted Basis

Retrieved on: 
Tuesday, April 25, 2023
Organic Food, Retail, Health, Agriculture, Fitness & Nutrition, Natural Resources, Food, Beverage, Sugar substitute, ADM, Nutrition, Segment, Association of Jewish Aging Services, Wilmar, Business, Risk management, Animal nutrition, Central Time, Dicarboxylic acid, Sale, Dislocation, Human nutrition, Starch, Webcast, EPS, Vegetable oil, Wellness, Insurance, Coffee, Beer, Corporation, International

In South American origination, excellent risk management and higher export demand due to the record Brazilian soybean crop drove significantly higher year-over-year results.

Key Points: 
  • In South American origination, excellent risk management and higher export demand due to the record Brazilian soybean crop drove significantly higher year-over-year results.
  • In EMEA, crush margins were lower year-over-year as trade flows adjusted from the dislocations caused last year by the war in Ukraine.
  • Other Business results were significantly higher than the prior-year quarter due to improved ADM Investor Services earnings on higher interest income.
  • As additional information to help clarify underlying business performance, the table on page 10 includes reported earnings and EPS as well as adjusted earnings and EPS.

Balchem Corporation Reports Fourth Quarter Net Sales Growth of 9.1% and Strong Full Year 2022 Results

Retrieved on: 
Friday, February 24, 2023
ID, Food, Bergstrom, Public expenditure, Insurance, GAAP, Acquisition, Nutrient, Animal nutrition, Growth, Kappa, CFO, Human nutrition, Mineral, Calumet Specialty Products Partners, Health, Bank, Video game, Pharmaceutical industry

Financial Results for the Fourth Quarter of 2022:

Key Points: 
  • Financial Results for the Fourth Quarter of 2022:
    The Human Nutrition & Health segment generated fourth quarter sales of $130.4 million, an increase of $14.9 million or 12.9% compared to the prior year quarter.
  • Fourth quarter earnings from operations for this segment were $17.5 million for both 2022 and 2021.
  • The Animal Nutrition & Health segment generated quarterly sales of $64.8 million, a decrease of $0.2 million or 0.3% compared to the prior year quarter.
  • Interest expense was $5.1 million and $0.6 million in the fourth quarter of 2022 and 2021, respectively.

ADM Reports Fourth Quarter Earnings per Share of $1.84, $1.93 on an Adjusted Basis; Increasing Quarterly Dividend 12.5% to $0.45 per share

Retrieved on: 
Thursday, January 26, 2023
Supply Chain Management, Retail, Health, Agriculture, Fitness & Nutrition, Natural Resources, Food, Beverage, EPS, Lysine, Central Time, Water, RPO, ADM, Acquisition, Maintenance, Ethanol, Business, GAAP, Webcast, Animal nutrition, Sale, Starch, International, Risk, Wilmar, Human nutrition, Sugar substitute, Association of Jewish Aging Services, Dicarboxylic acid, Environment, Nutrition, Segment, Insurance, Oil, Fine chemical, Bank, Corporation

Global Trade results were lower than the strong fourth quarter of 2021, with lower ocean freight results partially offset by higher results in EMEA origination and destination marketing.

Key Points: 
  • Global Trade results were lower than the strong fourth quarter of 2021, with lower ocean freight results partially offset by higher results in EMEA origination and destination marketing.
  • The business benefited from a $110 million legal recovery related to the 2019 and 2020 closure of the Reserve, Louisiana, export facility.
  • In North America, strong export volumes for soybean meal and growing domestic demand for renewable diesel contributed to strong margins.
  • In EMEA, oil demand powered strong rapeseed margins, more than offsetting higher energy costs compared to the prior year.